Nowadays, many people face ongoing mental and physical health challenges that affect their daily lives. However, access to plant-based therapy options remains limited. PhytoXtract is committed to changing this by improving access to regulated, plant-based substances for medical use, while promoting the well-being of both people and the environment.
plant-based narcotics
regulated substances for medical use
As one of the pioneering companies in the field, PhytoXtract, based in Zurich and Geneva, was among the first to be licensed by Swissmedic for medical cannabis. Adhering to the highest GMP (Good Manufacturing Practices) and GDP (Good Distribution Practices) standards, PhytoXtract supports access, innovation, and research in collaboration with pharmacies, hospitals, and academic institutions. With full control over the value chain, from working with organic cultivation partners to operating its own pharmaceutical laboratories, PhytoXtract ensures quality and traceability at every step. Plant-based narcotics are regulated substances for medical use, derived from medicinal plants such as cannabis.
swiss quality
reliable standards and cost efficiency
PhytoXtract specializes in Swiss cannabis encompassing cultivation, extraction, formulation, and analysis. We comply with pharmaceutical, technical, and food-grade quality standards, and operate in full compliance with GMP and GDP - standards while strictly following the rules and regulations of Switzerland. We are committed to consistent quality and cost efficiency – supporting access to reliable, high-standard products for medical use.
SIMPLE
large product selection and possibility to order custom-made products as neededSIDE BY SIDE
regular visits from our specialists, training and access to research and market updatesSUSTAINABLE
commitment to environmental considerations from seed to salemedical cannabis : CBD and THC
The production of medical cannabis must follow strict GMP standards for both finished pharmaceutical products and active substances, in line with Swiss GMP and EU-GMP guidelines (Part I: pharmaceutical products, Part II: active ingredients). As a licensed manufacturer, PhytoXtract supports the production of fully regulated cannabis-based preparations, listed in the Swiss pharmacopoeia, and contributes to their safe and responsible availability.
It all begins with the plant. For outdoor cultivation, growers must follow GACP (Good Agricultural and Collection Practices). Indoor cultivation is subject to GMP (Good Manufacturing Practices), as it qualifies as pharmaceutical manufacturing. These regulatory frameworks form the foundation of our quality assurance system, ensuring consistent and traceable raw material quality. From carefully selected dried cannabis flowers, PhytoXtract manufactures pharmaceutical-grade cannabis raw materials as well as custom CBD/THC extracts and formulations tailored for pharmacies and pharmaceutical partners. We offer a variety of CBD:THC ratios in formats such as full-spectrum, broad-spectrum, and isolate-based oils, all produced under GMP conditions.
Beyond the pharmaceutical sector, we also serve broader industry needs. All product lines follow a fully traceable quality and compliance system, with in-house formulation and manufacturing of bulk extracts, white-label solutions, and raw materials for B2B partners.
next plants : stay tuned
We are continuously exploring regulated, plant-based substances with potential medical use. Drawing on scientific research and pharmaceutical standards, we aim to contribute to the development of safe, evidence-based options derived from nature.
Stay tuned as we expand our portfolio – combining innovation with sustainability to support future therapeutic strategies.
CANMED [DE] - Die Informationsplattform für verschreibende Ärzt:innen
Die Verschreibung von Medizinalcannabis erfordert einen individuellen Ansatz – denn Verträglichkeit und Wirkung können je nach Patient:in variieren und hängen unter anderem vom Endocannabinoid-System, der Begleitmedikation und weiteren Faktoren ab.
CANMED bietet Ärzt:innen evidenzbasierte Fachinformationen, Studienübersichten und praktischen Tools rund um die Verschreibung von Medizinalcannabis, um Sie im Praxisalltag effizient zu unterstützen.
Haben Sie Fragen?
Kontaktieren Sie uns gern unter aerzte@phytoxtract.ch für weitere Informationen oder Unterstützung.
CANMED [FR] - La plateforme d'information pour les médecins prescripteurs
La prescription de cannabis médical nécessite une approche individuelle, car la tolérance et les effets peuvent varier d'un patient à l'autre et dépendent, entre autres, du système endocannabinoïde, des médicaments concomitants et d'autres facteurs.
CANMED fournit aux médecins des informations spécialisées fondées sur des preuves, des synthèses d'études et des outils pratiques sur la prescription de cannabis médical afin de les aider efficacement dans leur pratique quotidienne.
Vous avez des questions?
N'hésitez pas à nous contacter à l'adresse medecins@phytoxtract.ch pour obtenir de plus amples informations ou de l'aide.
PhytoXtract is a Swissmedic-certified laboratory offering contract manufacturing services for magistral preparations and raw materials. Operating under strict GMP pharmaceutical standards, we ensure the highest level of quality, safety, and compliance.
Our expertise in extracting and processing medicinal plants enables us to deliver reliable, pharmaceutical-grade formulations and raw materials tailored to your needs. By partnering with PhytoXtract, pharmacies and pharmaceutical laboratories can confidently outsource production, streamline internal processes, and provide patients with customized, high-quality preparations, backed by the assurance of Swissmedic certification.
